Pharmaceuticals APAC News & Press Release Distribution

Pharmaceuticals

All
Global

EVERSANA™ Announces Strategic Partnership with Compai Pharma to Expand Commercialisation Services Across the Asia Pacific Region

CHICAGO and SINGAPORE, July 13, 2022 /PRNewswire/ -- EVERSANA™, a pioneer of next-generation commercial services to the global life sciences industry with its Asian regional headquarters inSingapore and offices across Japan, China and other countries in the area, and Compai Pharma, an enterprisin...

2022-07-13 08:57 2643

Amaran Biotech Introduces the First Fully-Automated Robotic Aseptic Filling Line in Taiwan During Bio Asia-Taiwan 2022 7/28-7/31

HSINCHU, July 13, 2022 /PRNewswire/ -- Amaran Biotechnology Inc., a subsidiary ofTaiwan's OBI Pharma Inc., today announced that the construction of its fully-automated aseptic filling line and facilities, a first inTaiwan, has been completed. The new facility minimizes the risks of human factors ...

2022-07-13 08:00 5059

Amaran Biotech Introduces the First Fully-Automated Robotic Aseptic Filling Line in Taiwan During Bio Asia-Taiwan 2022 7/28-7/31

U.S. Government Secures 3.2 Million Doses of Novavax COVID-19 Vaccine

* Agreement will provide the first protein-based vaccine option in the U.S., pending FDA Emergency Use Authorization and CDC recommendation GAITHERSBURG, Md. ,July 11, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-gene...

2022-07-11 20:10 4823

SCG Cell Therapy Announces U.S FDA Clearance of Investigational New Drug Application for SCG101, SCG's Novel TCR-T Cell Therapy For Hepatitis B-related Liver Cancers

SINGAPORE, July 11, 2022 /PRNewswire/ -- Singapore-based SCG Cell Therapy Pte Ltd ("SCG") announced that U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for SCG101, an investigational T-cell receptor (TCR) T cell therapy for patients with hepati...

2022-07-11 13:34 3188

Kevin Richardson appointed as CEO, Telix Americas

MELBOURNE and INDIANAPOLIS, July 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce thatKevin Richardson, a senior global executive with a career focus on sales, marketing and business operations in the oncology and radiopharmaceutical mar...

2022-07-11 08:13 3613

HaemaLogiX strengthens Board with appointment of Dr. Geoff Nichol

* Dr. Geoff Nichol, M.B., Ch.B., M.B.A., joins HaemaLogiX's Board of Directors as Non-Executive Director, bringing nearly 30 years of global drug development experience * Past achievements include approval of Augmentin BID for adults and children, plus foundational clinical development of bre...

2022-07-08 05:30 3598

Insilico Medicine identified multiple new targets for amyotrophic lateral sclerosis (ALS) using its AI-driven target discovery engine

* Insilico and its collaborators scoured massive datasets and found genes relevant to ALS through PandaOmics™, Insilico's proprietary AI-driven target identification engine. * 28 targets were identified from CNS and diMN samples; for 18 targets (64%), suppression moderately or strongly rescue...

2022-07-08 04:00 4004

Brii Biosciences Announces Commercial Launch of its Amubarvimab/Romlusevimab Combination Therapy for COVID-19 in China

The Company is working closely with its commercial partners to supply the combination therapy to patients in need Brii Bio progressed the combination therapy from discovery to global Phase 3 data readout and first regulatory approval by the China NMPA in less than 20 months, validating the Com...

2022-07-07 07:10 5249

Guardant Health and Adicon announce strategic partnership to offer comprehensive genomic profiling tests to accelerate development of new cancer therapies in China

Collaboration will provide biopharmaceutical companies access to Guardant Health's broad portfolio of cancer tests to help advance drug development programs and their clinical trials SINGAPORE, July 6, 2022 /PRNewswire/ -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company,...

2022-07-06 18:17 5608

Ascletis Announces U.S. IND Filing of Oral RdRp Inhibitor Drug Candidate ASC10 for COVID-19

-- ASC10 is an oral small molecule drug candidate, which is in-house discovered and developed, and Ascletis retains full global rights for its development and commercialization --This IND filing of ASC10 in the U.S. will accelerate Ascletis' global multi-center clinical studies on ASC10 and bett...

2022-07-06 08:10 5022

Novavax Nuvaxovid™ COVID-19 Vaccine Conditionally Authorized in the European Union for Adolescents Aged 12 Through 17

* Nuvaxovid™ COVID-19 vaccine is the first protein-based option for adolescents aged 12 through 17 inEurope GAITHERSBURG, Md., July 5, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious inf...

2022-07-05 23:37 4773

Endurance RP Limited (SEHK:0575.HK) Operational Update on the PE Prevention Drug Fortacin™ / Senstend™

Phase 3 Study in China is Estimated to Complete in November 2022 HONG KONG, July 5, 2022 /PRNewswire/ -- Endurance RP Limited ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) is pleased to provide updates on the PE prevention drug - Fo...

2022-07-05 12:06 4287

JW Therapeutics Announces Initiation of Clinical Study of JWATM204 in Patients with Advanced Hepatocellular Carcinoma

SHANGHAI, July 4, 2022 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the initiation of phase I clinical study of JWATM204 in patients with advanced ...

2022-07-04 19:30 6009

Octapharma shares new data at ISTH 2022 in its mission to meet the challenges faced by people with bleeding disorders

LACHEN, Switzerland, July 4, 2022 /PRNewswire/ -- * Octapharma to present new clinical and scientific data from across Octapharma's haematology and critical care portfolios during the ISTH 2022 Congress * Data to be presented in 11 poster presentations and during two Supported Symposia * N...

2022-07-04 18:00 4069

Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV Infection

HANGZHOU and SHAOXING, China, July 4, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that the clinical study of PD-L1 antibody ASC22 in combination with Chidamide for functional cure of human immunodeficiency virus (HIV) infection, which was initiated by Shangh...

2022-07-04 08:10 3830

Innovent Announces First Patient Dosed in a Phase 2 Clinical study of IBI112 (IL-23p19 Monoclonal Antibody) in Patients with Moderate-to-Severe Active Ulcerative Colitis

SAN FRANCISCO and SUZHOU, China, July 4, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, autoimmune, metabolic, ophthalmology and ot...

2022-07-04 08:00 4145

Brii Biosciences Exercises Option for Vir Biotechnology's VIR-3434, a Broadly Neutralizing Monoclonal Antibody Targeting Hepatitis B in Greater China

Exclusive development and commercialization rights to VIR-3434 in China strengthen Company's leadership and robust clinical pipeline in HBV Key partnership with Vir enables multitude of combination treatment options as part of Company's strategic approach to developing a functional cure for HBV ...

2022-07-04 07:10 4677

GSK Spreads Awareness on Vaccine-Preventable Diseases, Attempting to Bridge the Vaccination Gap in Malaysia

Building public trust and educating on the importance of getting vaccinated KUALA LUMPUR, Malaysia, July 1, 2022 /PRNewswire/ -- GSK is a science-led global healthcare company, delivering vaccines that help protect people at all stages of life. GSK's new purpose is to unite science, technology an...

2022-07-01 09:16 3694

GSK Spreads Awareness on Vaccine-Preventable Diseases, Attempting to Bridge the Vaccination Gap in Malaysia

Fosun's Businesses Shows Strong Recovery Momentum as Consumption Regains Vitality and Tourism Industry Continues to Recover

HONG KONG, June 30, 2022 /PRNewswire/ -- The Bund Finance Center (BFC) in Shanghai officially resumed dine-in services at restaurants starting from 29 June. At present, Fosun's businesses and shopping centers inShanghai, including the BFC, Yuyuan Tourist Mart, Forte Woli City, and Orstar City Zhe...

2022-06-30 20:43 4958

Fosun's Businesses Shows Strong Recovery Momentum as Consumption Regains Vitality and Tourism Industry Continues to Recover

Australian developed VIRALEZE™ nasal spray relaunched by LloydsPharmacy in the UK

MELBOURNE, Australia, June 30, 2022 /PRNewswire/ -- UK consumers will again be able to buy VIRALEZE™, an easy-to-use barrier nasal spray, from LloydsPharmacy, following its relaunch online, with instore availability to follow shortly. Extensive antiviral testing undertaken at the globally renowne...

2022-06-30 12:41 2421

1 ... 145 146 147148149 150 151 ... 184